Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the exchanges that its trading window will be closed from July 1, 2025, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). During this period, insiders, designated persons, and their immediate relatives are prohibited from trading in the company's shares. The board meeting date to approve the Q1 results will be announced separately. The filing is made under SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine compliance announcement and does not impact the stock price or shareholders directly. However, it signals that the company's Q1 FY26 results are upcoming, which investors should watch for fundamental updates.